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ABSTRACT
Introduction: Minimally invasive surgery has been ap-
plied in several ways to esophagectomy. Newer tech-
niques have improved patient outcomes while maintain-
ing oncological principles; however, mortality still exists.
Most series have reported mortality rates ranging from 2%
to 25%. The aim of this study was to determine the efficacy
of minimally invasive esophagectomies (MIE) in a non-
university tertiary care center.
Methods: MIE in the form of a combined thoracoscopic
and laparoscopic technique was performed cooperatively
by 2 surgeons. Records of patients who underwent MIE
between September 2005 and August 2008 were retro-
spectively reviewed.
Results: Thirty-four patients underwent MIE over a
3-year period. There was a male predominance. Mean
age at presentation was 62.6 years. Comorbidities were
documented in 79% of the patients. Most patients (68%)
presented with dysphagia. Two patients had end-stage
achalasia, 1 had corrosive esophageal stricture, and 31
had esophageal malignancies. No mortalities were re-
ported. No anastomotic leaks were observed. Eighteen
(58%) patients with malignancy received preoperative
chemoradiotherapy. Six (33%) patients had a patholog-
ical response (CR) on final histopathology. The mean
operating time was 294 minutes. The mean blood loss
was 302 mL.
Conclusions: Minimally invasive esophagectomy can be
performed with results that meet and exceed reported
benchmarks. A team-based approach greatly impacts the
outcome of the surgery. This surgical technique must be
standardized to achieve this outcome.
Key Words: Minimally invasive esophagectomy, Anasto-
motic leak, Outcomes.
INTRODUCTION
Esophagectomy is a complex procedure involving multi-
ple fields of dissection. It is the treatment of choice for
esophageal neoplasms and, sometimes, benign disorders,
such as end-stage achalasia and corrosive strictures.
Esophagectomy has been associated with high mortality
and morbidity rates from the time it was first performed.
The esophagectomy techniques (transthoracic, transhiatal,
or 3-field approach) and the fields of lymphadenectomies
have been an area of debate. However, many studies
report equivocal outcomes.1,2 Minimally invasive surgery
has been applied in several ways to esophagectomy:
transhiatal, thoracoscopy with laparotomy and cervical
anastomosis, thoracotomy with laparoscopy, and lastly
thoracoscopy and laparoscopy with cervical or intratho-
racic anastomosis. Many centers worldwide have reported
on their experiences with esophagectomy using various
minimally invasive techniques.3,4 In recent years, with the
availability of improved surgical technology and advances
in intensive care, the operative outcome has improved
significantly. This has led to an interest in newer tech-
niques that provide improved patient outcomes while
maintaining sound oncological principles. The purpose of
this report is to describe a novel technique for minimally
invasive esophagectomy that has resulted in an excellent
outcome in a very ill group of patients. Moreover, the key
components of success necessary to improve outcomes in
this complex group of patients are examined.
The study was performed to describe (1) a modified
technique for performing minimally invasive esopha-
gectomy. In patients with cancer, this technique pro-
vides for sound oncologic principles with 3-field dis-
section; (2) to examine the surgical outcomes after
minimally invasive esophagectomy; (3) to discuss the
Cancer Center, Methodist Dallas Medical Center, Dallas, Texas, USA (Dr Khithani,
Ms Vo).
Department of Cardiothoracic Surgery, Methodist Dallas Medical Center, Dallas,
Texas, USA (Dr Jay).
Upper Gastrointestinal Surgery, Methodist Dallas Medical Center, Dallas, Texas,
and Hepatobiliary and Pancreatic Disease Center, USA (Drs Curtis, Jeyarajah).
Address correspondence to: D. Rohan Jeyarajah, MD, Director Surgical Oncology
and Upper Gastrointestinal fellowship, Methodist Dallas Medical Center, 221 West
Colorado Blvd, Ste 100, Dallas, Texas 75208, USA. Telephone: (214) 943-8605, Fax:
(214) 946-8339, E-mail: rjeyar@sadtx.com
DOI: 10.4293/108680809X12589998404326
© 2009 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. Published by
the Society of Laparoendoscopic Surgeons, Inc.
JSLS (2009)13:542–549 542
SCIENTIFIC PAPERcomponents of the process that are required to attain
favorable procedure-related outcomes.
Long-term oncologic outcomes were not the object of this
study because of the small sample size and the short
duration of follow-up.
METHODS
Minimally invasive esophagectomy (MIE) in the form of
combined thoracoscopic and laparoscopic esophageal
resections performed cooperatively by 2 surgeons (DRJ
and JJ) between September 2005 and August 2008 were
retrospectively reviewed. The Methodist Dallas Medical
Center Institutional Review Board approved the study
design. Patient-related data, including age, sex, medical
history, presenting symptoms, preoperative weight, and
need for preoperative stenting, were collected. Intraop-
erative data including estimated blood loss, operative
time, need for intraoperative blood transfusions, type of
reconstruction, and ASA class were collected. Postop-
erative data including length of hospital stay, need for
intensive care unit, need for postoperative blood trans-
fusions, morbidities, and 30-day mortality were evalu-
ated. Histopathologic data including tumor type, mar-
gin status, and nodal status were collected. All patients
underwent preoperative staging with computerized ax-
ial tomography (CAT) scans. Barium swallow and
positron emission tomography (PET) scans were ob-
tained when clinically indicated. Endoscopic ultra-
sound (EUS) was performed in all patients with malig-
nant disease. Patients diagnosed with early stage
esophageal cancer (less that T3 lesions with no clinical
or EUS noted node positivity) were taken to surgery
without preoperative chemotherapy or radiation ther-
apy. Patients with extensive local disease were treated
with neoadjuvant chemoradiotherapy. Patients who
were to receive preoperative therapy who had signifi-
cant dysphagia received laparoscopic feeding tube
placement and mediport insertion while under the same
anesthesia before the commencement of neoadjuvant
therapy. This also permitted simultaneous staging for
metastasis to the liver and peritoneum. The esophagec-
tomy procedure was performed as outlined below. This
was performed 6 weeks to 12 weeks after completion of
radiation therapy in those patients who received pre-
operative treatment. All patients underwent Gastrogra-
fin, followed by barium swallow to assess patency of
the esophagogastric anastomosis on the sixth postop-
erative day. The nasogastric tube was removed, and the
diet was advanced gradually. Jejunal tube feeding was
utilized until the patient could take adequate oral sup-
plementation.
Operative Technique
To adhere to sound oncological principles, it is the
feeling of the authors that a 3-field approach is war-
ranted. The authors favor a neck anastomosis. While
this approach results in less morbidity if there is a leak,
the inherent greater risk exists of injury to the recurrent
laryngeal nerve. Wide resection of previously radiated
tissue with anastomosis of fresh stomach to esophagus
is the authors’ preference. Lack of conduit length has
not been a concern in the authors’ hands. Therefore,
the authors have adopted a routine cervical anastomotic
technique. Specifically, the technique involves thoraco-
scopic mobilization of the esophagus in the chest; lapa-
roscopic mobilization of the stomach; minilaparotomy
to retrieve the specimen and to perform the pyloro-
plasty and Kocher maneuver; and open neck incision
with passage of the gastric pull-up to the neck from the
abdomen and performed as follows.
Thoracoscopic mobilization of the esophagus in
the chest
The patient is placed in a left lateral decubitus position
and is secured with a beanbag. Single-lung ventilation is
achieved by using a double-lumen endotracheal tube, and
thoracoscopic trocars are placed as outlined in Figure 1.
It is critical to place the camera port as inferiorly as
possible on the chest wall, while staying above the dia-
phragm. This allows the working surgeon to work head-
ing cephalad, rather that towards the feet, or backwards.
The retractor port should be just inferior to the scapula.
The esophagus is detached from its blood supply, and the
azygous vein is divided using a stapler with a vascular
load. Encircling the esophagus with a Penrose drain will
allow easier retraction as the dissection is carried out
towards the thoracic inlet. It is difficult, and not necessary,
to dissect inferiorly towards the hiatus, as this can be done
with ease from the abdomen. A single 32Fr pleural tube is
left in place after the thoracic procedure. No epidural
catheter is placed. Specifically with regards to the thoracic
nodal clearance, local nodes in the paraesophageal, para-
tracheal, and subcarinal stations are taken. However, the
authors do not make any attempt to perform a more
extensive nodal dissection.
Laparoscopic mobilization of the stomach
The patient is then placed in leg splitter position, and
the operating surgeon stands to the patient’s right side,
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shown in Figure 2. It is important that the retractor port
is placed in as far to the patient’s right as possible and
as directly subcostal as possible. This allows the retrac-
tor not to interfere with the work of the operating
surgeon. The short gastric vessels are taken using the
Harmonic scalpel, the greater curvature is mobilized
completely, and the hiatus is then dissected completely.
The esophagus can be encircled with a Penrose drain to
assist with retraction. The left gastric vascular bundle is
taken with a vascular stapler as low as possible to
include the celiac nodes. Specific celiac skeletonization
is not routinely performed unless clinically concerning
nodes are present.
Minilaparotomy to retrieve the specimen and to
perform the pyloroplasty and Kocher maneuver
At this time, the trocars are removed, and a small incision
is made vertically around the camera port. This is carried
out so as to permit a hand 3 inches to 4 inches into the
abdomen. A Kocher maneuver is performed, and a Hei-
neke-Mikulicz pyloroplasty is performed in a single layer,
both under direct visualization. It is important that the
Kocher maneuver be generous such that the pylorus
reaches the hiatus. This helps to decrease any tension on
the conduit and will decrease bile reflux in the future. The
authors have not had any issues with conduit length if this
technique is adhered to. The authors have found over
time that the open pyloroplasty through a minilaparotomy
incision has saved time and effort compared with their
older technique of a fully minimally invasive approach.
The ports have to be adjusted to view the pylorus ade-
quately, and this was found to be cumbersome. Any
attachments in the mediastinum can be bluntly dissected
with a hand. It is important that the hiatus be manually
widened so as not to impinge on the conduit as it ascends
into the chest. The use of laparoscopy results in the hiatus
being narrowed, and this will impede egress of conduit
into the chest and neck resulting in a lack of length.
Open neck incision with passage of the gastric
pull-up to the neck from the abdomen
The left neck is then opened, and the esophagus is encir-
cled. It is important to minimize cautery and dissection in
the tracheoesophageal groove to decrease the risk of
Figure 1. Port placement for thoracoscopic esophageal mobili-
zation.
Figure 2. Port placement for laparoscopic component.
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made to perform a specific nodal dissection in the neck.
The dissection is continued into the posterior mediasti-
num until the esophagus is completely free. The esopha-
gus is then transected in the neck. A sterile nasogastric
tube is attached to the specimen side, and the specimen is
retrieved through the abdomen. The stomach is transected
by using a stapler with minimal tubularization. The celiac
nodes on the lesser curvature should be included in the
specimen. The sterile nasogastric tube lying in the poste-
rior mediastinum is attached to the conduit, which is
pulled up to the neck. A partially stapled anastomosis is
then performed in the neck. The cervical esophagogastric
anastomosis is done using the Orringer technique, which
is a side to side posterior stapled layer followed by an
interrupted anterior hand sewn layer.5 The neck is ex-
plored solely for the purpose of obtaining a cervical
esophagogastric anastomosis. A cervical lymphadenec-
tomy is not performed. The procedure is then completed
after one drain and a feeding jejunostomy tube are placed
in the neck, if this had not already been placed preoper-
atively.
RESULTS
During the time frame of this study, 34 patients underwent
minimally invasive esophagectomy.
Preoperative Factors
Patient demographic data are shown in Table 1. There
was a male predominance in the study. Mean age at
presentation was 62.6 years (SD14.3, range 20 to 83).
Comorbidities were documented in 79% of the study
group. The comorbidities were defined as preoperative
medical conditions that are known to affect perioperative
outcome in patients undergoing surgery, such as ischemic
heart disease, COPD, diabetes mellitus, syndrome of in-
appropriate antidiuretic hormone secretion. The majority
of patients had multiple comorbidities. Most patients
(68%) presented with dysphagia. All patients underwent a
preoperative CAT scan. Two patients were operated on
for end-stage achalasia. They had both failed prior Heller
myotomy, whereas one patient was operated on for cor-
rosive stricture of the esophagus secondary to lye inges-
tion. Eighteen (58%) patients with malignancy received
preoperative chemoradiotherapy. One patient underwent
preoperative esophageal stenting to aid in swallowing.
Operative Factors
Operative-related factors are shown in Table 2. The ma-
jority of patients (94%) were either ASA class III or IV.
Mean operating time was 294 minutes (SD68.3, range
199 to 462). Mean estimated blood loss was 302mL
(SD137, range 100 to 700). Seven (21%) patients re-
ceived intraoperative blood transfusions, while 4 (12%)
received blood in the postoperative period. Three patients
(9%) required nonemergent extension one of which was a
minithoracotomy due to adhesions around the bronchus.
Two patients underwent conversion of the abdominal
component with a minilaparotomy incision one each for
adequate left gastric clearance and adhesions in the lower
thorax and perihiatal area. Both patients who had known
esophageal and gastric involvement received neoadjuvant
therapy to downstage as much as possible with an antic-
ipation for total gastrectomy. Two patients underwent a
Table 1.
Preoperative Data
Parameter No. of Patients %
Total Esophagectomies 34
Males/Females 21/13 62/38
Presenting Symptoms
Dysphagia 21 68
Reflux 13 38
Pain 3 9
Vomiting 4 12
GI Bleed 3 9
Anemia 3 9
Asymptomatic 3 9
Odynophagia 2 6
Respiratory Symptoms 3 9
Mean Age (yrs)  SD*
(Range)
62.6 yrs  14.3 20–83
years
Mean Weight  SD*
(Range)
79.8 kg  17.1 52–134
kg
Mean BMI  SD*
(Range)
27  5.93 (19– 40)
Comorbidities: Diabetes,
Ischemic Heart Disease,
COPD, etc.
27 79
Previous Major
Abdominal Surgery
61 8
Previous Thoracic
Surgery
13
Esophageal Stenting 1 3
Neoadjuvant
Chemoradiotherapy
18 58
*SD  standard deviation; BMI  body mass index.
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sis in the neck. This was done due to a positive stomach
margin. The remnant stomach was inadequate to con-
struct the gastric tube for cervical anastomosis. These
were performed with a hand-assisted laparoscopic tech-
nique.
Postoperative Data
Postoperative data are shown in Table 3. No mortalities
occurred in the series. The overall morbidity rate was 61%.
No anastomotic leaks occurred in any of the patients.
Sixty-one percent of the patients who underwent neoad-
juvant therapy developed morbidities. Reoperation was
necessary in 3 (9%) patients, all for closure for abdominal
dehiscence. Amongst the patients who developed wound
dehiscence, one had received neoadjuvant therapy and
another had undergone an extension to a laparotomy.
Delayed gastric emptying was defined as the inability to
feed orally or as delayed emptying seen radiologically.
Three patients developed an anastomotic stricture; one of
these patients underwent dilatation 4 weeks postopera-
tively, while the others underwent dilatation long after
from surgery.
Histopathological Data
The histopathological data are shown in Table 4. The
most common histopathologic diagnosis was adenocarci-
noma. One patient who was diagnosed preoperatively as
having Barrett’s with high-grade dysplasia had a stage I
adenocarcinoma on final histopathology. Eighteen pa-
tients received neoadjuvant chemoradiotherapy and sub-
sequently underwent MIE. Of these, 6 (33%) patients had
complete response to therapy in that there was no evi-
dence of disease on final histopathology. Two other pa-
tients with no residual primary tumor on final histopathol-
ogy had 1-mm tumor metastasis in the lymph nodes.
DISCUSSION
Esophagectomy is a challenging surgical technique. Vari-
ous open techniques depending on the location of the
tumor can be performed by general surgeons, surgical
oncologists, thoracic surgeons, and foregut surgeons.
Each group has a different skill set and bias leading to a
heterogeneous method of treating esophageal disease in
Table 2.
Intraoperative Data
ASA Classification (n)
ASA I 0
ASA II 2 (6%)
ASA III 18 (53%)
ASA IV 14 (41%)
Mean Estimated Blood Loss (mL)  SD* 302 mL  137
(Range ) (100–700 mL)
Mean Operative Time (min)  SD* 294 min  68.3
(Range) (199–462 min)
Intraoperative Blood Transfusions 7 (21%)
Extension to Open Celieotomy
Overall extension 3 (9%)
Extension to minithoracotomy 1 (3%)
Extension to minilaparotomy 2 (6%)
*SD  standard deviation.
Table 3.
Postoperative Data
Parameter
30 day postoperative mortality (n) 0
Postoperative Blood Tranfusions (n) 4 (12%)
Mean length of stay (days)  SD 14.6  10.4
Major Morbidity (n)
Delayed Gastric Emptying 5 (15%)
Cardiac Events 7 (21%)
Aspiration 6 (18%)
Wound Infection 2 (6%)
Wound dehiscence 3 (9%)
Vocal Cord Palsy 2 (6%)
Pneumonia 8 (24%)
Reintubation 4 (12%)
Intestinal Obstruction 1 (3%)
ARDS 1 (3%)
Minor Morbidity
UTI 5 (15%)
Anastomotic Stricture 3 (9%)
DVT 2 (6%)
Reoperation: Wound Repair (n) 3 (9%)
Non Surgical Reintervention: Esophageal
Dilatation (n)
1 (3%)
Ventilatory Support 24 hrs (n) 5 (15%)
*SD  standard deviation; ARDS  acute respiratory distress
syndrome; UTI  urinary tract infection; DVT  deep venous
thrombosis.
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proaches each have their benefits and drawbacks. There
has never been a clear oncological advantage to one over
the other.1,2 The major goal of esophageal surgery, how-
ever, should be to achieve low mortality and morbidity
rates with an equitable oncological survival benefit. This
study demonstrates that excellent results can be achieved
in high-risk patients undergoing major surgery with a
novel minimally invasive technique.
De Paula et al6 were among the first to report on laparo-
scopic transhiatal esophagectomies. Law et al7described
the technique of thoracoscopic esophageal mobilization.
Yamamoto et al8 suggest the feasibility of video-assisted
thoracoscopic surgery for thoracic mobilization not only
in terms of an improved postoperative outcome but also
in terms of equitable 5-year survivals. Subsequently Luke-
tich et al and Nguyen et al have reported on their expe-
riences with total thoracic with laparoscopic thoracic mo-
bilization and resection, suggesting that excellent results
can be obtained using minimally invasive techniques and
maintaining oncological standards as that in open esoph-
agectomy.9–11 Most series have reported mortality rates
ranging from 2% to 14%.9,11–14 However, the anastomotic
fistula rates in most series remain high.9,10,14 Importantly,
this paper demonstrates no mortalities in a group of pa-
tients with significant morbidities and with a zero leak
rate. This study demonstrates that the operating time can
be limited to 302 minutes in spite of the change in patient
positioning and 2 surgeons being involved in the surgery.
When comparing the aforementioned parameters with
reported series of open esophagectomies, this study dem-
onstrates a comparable operative outcome with no anas-
tomotic fistula rates.
Due to the complexity of the surgery and multiple dissec-
tion fields involved in patients often with a poor ASA
status, the development of a multidisciplinary team is the
critical factor in generating the outcome. Initial assessment
of the patient with esophageal disease includes risk strat-
ification of the comorbidities with the input of an excel-
lent pulmonologist and cardiologist. Staging of patients
with esophageal malignancies is crucial in delineating
who should go on to receive neoadjuvant treatment. Local
staging with EUS is crucial to determining who should
receive up-front treatment.15,16 A dedicated gastroenterol-
ogist who has EUS skills is essential. Pathologists familiar
with cytology are needed to evaluate fine-needle aspira-
tions of the lymph nodes.
Intraoperatively, an anesthesiologist familiar with cardiac
anesthesia and single-lung ventilation and the operating
team are important. The skill set required of the surgeon
will be discussed below. A dedicated scrub technician and
circulating nurse are needed to ensure that the flow of the
surgery is maintained without unnecessary delays.
Several other points are raised by the data presented in
this article:
1) What are the hospital-related factors that suggest that a
minimally invasive esophagectomy team can be assem-
bled?
2) What are the surgeon-related factors that allow the
surgeon to be able to develop the team?
Mortality and morbidity in complex surgeries are evalu-
ated as key components in assessing a surgeon’s, and
more importantly, an institution’s ability to manage high-
risk surgery. Preoperative preparation, especially in pa-
tients with multiple comorbidities, needs to be done to
Table 4.
Histopathological Data
Diagnosis No. Pts. (Unless Otherwise
Noted)
%
Total Malignant Tumors 31 91
Adenocarcinoma 21 62
Squamous carcinoma 7 20
High-grade dysplasia
with Barrett’s
39
Total Benign Conditions 3 9
End-stage achalasia 2 6
Corrosive stricture 1 3
Final Stage
Stage 0 3 9
Stage I 8 26
Stage IIA 7 23
Stage IIB 2 6
Stage III 3 9
YP0 8 26
Total Positive Tumor
Margins
39
Proximal margin
positive
26
Distal margin positive 1 3
Radial margin
positive
13
Mean Lymph Nodes
Retrieved  SD (Range)
11 nodes  5.44 (1–26)
JSLS (2009)13:542–549 547minimize perioperative risk. Selection of appropriate pa-
tients for minimally invasive esophagectomy and onco-
logic management of tumors after minimally invasive
esophagectomy requires the expertise of gastroenterolo-
gists with EUS skills, medical oncologists, and radiation
oncologists. Professionals with these specific skills should
be sought when building the team.
The nursing team needs to be carefully selected and
trained to be dedicated to patients who undergo mini-
mally invasive surgery. In fact, with careful education and
the development of a specific nursing team for both in-
traoperative and postoperative care, operative times and
the intensive care stay can be shortened. The authors have
identified a specific nursing supervisor in the operating
room to educate and train a set of nurses to take care of
patients who undergo minimally invasive surgery. Esoph-
agectomy mandates postoperative intensive care and ag-
gressive postpulmonary care. With minimally invasive
esophagectomy, the surgical insult can be reduced so as
to reduce the incidence of postoperative thoracic compli-
cations. A trained intensive care team lead by the operat-
ing surgeon can help achieve the same.
The surgeon factor is a difficult area to evaluate. The
surgeon must have a skill set that includes the following:
a) Thoracic surgery
b) Abdominal surgery
c) Minimally invasive surgical techniques (thoracoscopy
and laparoscopy)
d) Oncological principles
e) Critical care
The question is, can any one surgeon possess all of these
traits? It is the feeling of the authors that a team approach
is the best way to give the patient the best chance of
success. In fact, the thoracic surgeon might have the best
thoracic expertise, but he or she might not have the best
ability to mobilize the stomach. The surgical oncologist
has the best understanding of the behavior of malignant
tumors, but can he or she adequately understand benign
disease or minimally invasive techniques? It is with this
background that we feel that an organ-specific approach
to esophageal disease is important–treating benign dis-
ease improves one’s ability to treat malignant disease.
Given its technical challenges, it has become clear that this
operation should be performed by those who have com-
pleted a fellowship focusing specifically on esophageal
disease. The development of a dedicated upper gastroin-
testinal surgical fellowship at Methodist Hospital is one
example of such a training modality.
CONCLUSION
Minimally invasive esophagectomy can be performed
with results that meet and exceed reported benchmarks.
The surgical technique needs to be standardized to
achieve this outcome.
References:
1. Morgan MA, Lewis WG, Hopper AN, et al. Prospective com-
parison of transthoracic versus transhiatal esophagectomy fol-
lowing neoadjuvant therapy for esophageal cancer. Dis Esopha-
gus. 2007;20(3):225–231.
2. Boyle MJ, Franceschi D, Livingstone AS. Transhiatal versus
transthoracic esophagectomy: complication and survival rates.
Am Surg. 1999;65(12):1137–1141.
3. Bizekis C, Kent MS, Luketich JD, et al. Initial experience with
minimally invasive Ivor Lewis esophagectomy. Ann Thorac
Surg. 2006;82(2):402–406.
4. Qureshi I, Nason KS, Luketich JD. Is minimally invasive
esophagectomy indicated for cancer? Expert Rev Anticancer
Ther. 2008;8(9):1449–1460.
5. Mark B. Orringer, Becky Marshall, Mark D. Iannettoni, Elim-
inating the cervical esophagogastric anastomotic leak with a
side-to-side stapled anastomosis. J Thorac Cardiovasc Surg.
2000;119:277–288.
6. DePaula AL, Hashiba K, Ferreira EA, et al. Laparoscopic
transhiatal esophagectomy with esophagogastroplasty. Surg
Laparosc Endosc. 1995;5:1–5.
7. Law S, Fok M, Chu KM, Wong J. Thoracoscopic esophagec-
tomy for esophageal cancer. Surgery. 1997;122:8–14.
8. Yamamoto S, Kawahara K, Maekawa T, et al. Minimally
invasive esophagectomy for stage I and II esophageal cancer.
Ann Thorac Surg. 2005;80(6):2070–2075.
9. Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie
NA, et al. Minimally invasive esophagectomy: outcomes in 222
patients. Ann Surg. 2003;238(4):486–494.
10. Nguyen NT, Roberts P, Follette DM, Rivers R, Wolfe BM.
Thoracoscopic and laparoscopic esophagectomy for benign and
malignant disease: lessons learned from 46 consecutive proce-
dures. J Am Coll Surg. 2003;197(6):902–913.
11. Nguyen NT, Follette DM, Wolfe BM. Comparison of mini-
mally invasive esophagectomy with transthoracic and transhiatal
esophagectomy. Arch Surg. 2000;135:920–925.
12. Palanivelu C, Prakash A, Senthilkumar R. Minimally invasive
esophagectomy: thoracoscopic mobilization of the esophagus
Zero Leaks With Minimally Invsaive Esophagectomy: a Team-Based Approach, Khithani A et al.
JSLS (2009)13:542–549 548and mediastinal lymphadenectomy in prone position–experi-
ence of 130 patients. J Am Coll Surg. 2006;203(1):7–16.
13. Martin DJ, Bessell JR, Chew A, Watson DI. Thoracoscopic
and laparoscopic esophagectomy: initial experience and out-
comes. Surg Endosc. 2005;19(12):1597–1601.
14. Sanders G, Borie F, Husson E, et al. Minimally invasive
transhiatal esophagectomy: lessons learned. Surg Endosc. 2007;
21(7):1190–1193.
15. Lightdale CJ, Kulkarni KG. Role of endoscopic ultrasonog-
raphy in the staging and follow-up of esophageal cancer. J Clin
Oncol. 2005;23(20):4483–4489.
16. Zhang X, Watson DI, Lally C, Bessell JR. Endoscopic ultra-
sound for preoperative staging of esophageal carcinoma. Surg
Endosc. 2005;19(12):1618–1621.
JSLS (2009)13:542–549 549